CA Stock MarketDetailed Quotes

Universal Ibogaine Inc (IBO)

Watchlist
  • 0.005
  • 0.0000.00%
15min DelayMarket Closed Feb 2 16:00 ET
1.56MMarket Cap-0.25P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Universal Ibogaine Inc (IBO) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Apr 30, 2025
(Q2)Jan 31, 2025
(Q1)Oct 31, 2024
(FY)Jul 31, 2024
(Q4)Jul 31, 2024
(Q3)Apr 30, 2024
(Q2)Jan 31, 2024
(Q1)Oct 31, 2023
(FY)Jul 31, 2023
(Q4)Jul 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
77.98%-110.37K
-196.28%-201.57K
-33.35%-245.94K
23.58%-838.61K
-1,563.75%-84.93K
-191.16%-501.22K
85.84%-68.03K
59.05%-184.43K
74.67%-1.1M
100.34%5.8K
Net income from continuing operations
92.32%-66.2K
-37.00%-304.42K
-66.76%-346.61K
14.17%-2.05M
-182.22%-759.15K
-77.23%-862.39K
71.97%-222.2K
75.31%-207.85K
77.23%-2.39M
93.13%-269K
Depreciation and amortization
0.00%80.46K
8.90%89.15K
-3.94%80.46K
16.02%343.46K
10.69%97.38K
11.27%80.46K
17.91%81.86K
26.27%83.76K
11.13%296.05K
11.13%87.97K
Asset impairment expenditure
--0
----
----
173.39%984.19K
316.13%624.19K
--360K
----
----
-86.70%360K
-94.46%150K
Remuneration paid in stock
--0
--0
-77.26%1.8K
-120.36%-19.69K
-89.00%-45.32K
-75.44%6.31K
539.42%11.43K
-91.91%7.9K
-89.30%96.7K
-119.66%-23.98K
Other non cashItems
-9.92%5.33K
-49.59%2.98K
0.00%5.92K
207.35%134.28K
12,301.15%116.52K
-65.82%5.92K
-78.33%5.92K
--5.92K
-98.44%43.69K
-95,600.00%-955
Change In working capital
-42.00%-129.97K
-80.49%10.72K
116.84%12.49K
-146.17%-229.27K
-291.95%-118.55K
-145.97%-91.53K
577.77%54.96K
-132.58%-74.16K
197.81%496.6K
108.79%61.76K
-Change in receivables
----
----
132.00%54.53K
-176.29%-118.3K
-59.77%23.85K
----
----
-248.89%-170.39K
5,961.69%155.06K
--59.27K
-Change in prepaid assets
----
----
-48.40%12.26K
-220.61%-6.39K
-139.79%-20.91K
----
----
17.88%23.76K
114.76%5.29K
--52.56K
-Change in payables and accrued expense
----
----
-47.91%49.03K
-158.30%-134.23K
-621.87%-123.92K
----
----
1.20%94.13K
148.53%230.25K
---17.17K
-Change in other working capital
----
----
-376.88%-103.34K
-72.04%29.64K
107.40%2.44K
----
----
---21.67K
--106K
---32.9K
Cash from discontinued investing activities
Operating cash flow
77.98%-110.37K
-196.28%-201.57K
-33.35%-245.94K
23.58%-838.61K
-1,563.75%-84.93K
-191.16%-501.22K
85.84%-68.03K
59.05%-184.43K
74.67%-1.1M
100.34%5.8K
Investing cash flow
Cash flow from continuing investing activities
0
0
96.55%-1.05K
78.18%-78.56K
-15.61%-19.64K
54.82%-19.31K
95.65%-9.17K
66.00%-30.44K
82.77%-360.04K
-102.80%-16.99K
Net PPE purchase and sale
--0
--0
96.55%-1.05K
78.18%-78.56K
-15.61%-19.64K
54.82%-19.31K
95.65%-9.17K
66.00%-30.44K
-329.51%-360.04K
-44.39%-16.99K
Cash from discontinued investing activities
Investing cash flow
--0
--0
96.55%-1.05K
78.18%-78.56K
-15.61%-19.64K
54.82%-19.31K
95.65%-9.17K
66.00%-30.44K
82.77%-360.04K
-102.80%-16.99K
Financing cash flow
Cash flow from continuing financing activities
-105.74%-35.95K
36.24%383.8K
-151.82%-31.97K
-6.69%974.7K
118.37%5.25K
66.53%626.05K
56.75%281.7K
-88.08%61.7K
-85.09%1.04M
76.54%-28.6K
Net issuance payments of debt
0.85%-32.45K
0.89%-32.01K
16.53%-31.97K
-121.78%-225.37K
-326.78%-122.04K
-108.71%-32.73K
-117.97%-32.3K
-107.55%-38.3K
-14.33%1.03M
76.54%-28.6K
Net common stock issuance
--0
--0
--0
12,027.69%1.21M
--130K
--665.58K
--317.19K
900.00%100K
-99.84%10K
--0
Net other financing activities
48.50%-3.5K
13,130.65%415.81K
----
---12.69K
---2.71K
---6.8K
---3.19K
----
----
----
Cash from discontinued financing activities
Financing cash flow
-105.74%-35.95K
36.24%383.8K
-151.82%-31.97K
-6.69%974.7K
118.37%5.25K
66.53%626.05K
56.75%281.7K
-88.08%61.7K
-85.09%1.04M
76.54%-28.6K
Net cash flow
Beginning cash position
-24.83%274.06K
-42.64%91.83K
18.37%370.8K
-56.85%313.26K
33.16%470.11K
89.89%364.59K
-77.25%160.09K
-56.85%313.26K
410.60%726.05K
-81.93%353.05K
Current changes in cash
-238.66%-146.32K
-10.89%182.23K
-82.13%-278.96K
113.94%57.53K
-149.63%-99.32K
-34.48%105.52K
139.97%204.5K
-584.62%-153.17K
-170.70%-412.78K
96.76%-39.79K
End cash Position
-72.83%127.75K
-24.83%274.06K
-42.64%91.83K
18.37%370.8K
18.37%370.8K
33.16%470.11K
89.89%364.59K
-77.25%160.09K
-56.85%313.26K
-56.85%313.26K
Free cash from
78.80%-110.37K
-161.08%-201.57K
-14.95%-246.99K
37.07%-917.17K
-834.50%-104.57K
-142.23%-520.53K
88.83%-77.21K
60.21%-214.87K
67.09%-1.46M
99.35%-11.19K
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Apr 30, 2025(Q2)Jan 31, 2025(Q1)Oct 31, 2024(FY)Jul 31, 2024(Q4)Jul 31, 2024(Q3)Apr 30, 2024(Q2)Jan 31, 2024(Q1)Oct 31, 2023(FY)Jul 31, 2023(Q4)Jul 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 77.98%-110.37K-196.28%-201.57K-33.35%-245.94K23.58%-838.61K-1,563.75%-84.93K-191.16%-501.22K85.84%-68.03K59.05%-184.43K74.67%-1.1M100.34%5.8K
Net income from continuing operations 92.32%-66.2K-37.00%-304.42K-66.76%-346.61K14.17%-2.05M-182.22%-759.15K-77.23%-862.39K71.97%-222.2K75.31%-207.85K77.23%-2.39M93.13%-269K
Depreciation and amortization 0.00%80.46K8.90%89.15K-3.94%80.46K16.02%343.46K10.69%97.38K11.27%80.46K17.91%81.86K26.27%83.76K11.13%296.05K11.13%87.97K
Asset impairment expenditure --0--------173.39%984.19K316.13%624.19K--360K---------86.70%360K-94.46%150K
Remuneration paid in stock --0--0-77.26%1.8K-120.36%-19.69K-89.00%-45.32K-75.44%6.31K539.42%11.43K-91.91%7.9K-89.30%96.7K-119.66%-23.98K
Other non cashItems -9.92%5.33K-49.59%2.98K0.00%5.92K207.35%134.28K12,301.15%116.52K-65.82%5.92K-78.33%5.92K--5.92K-98.44%43.69K-95,600.00%-955
Change In working capital -42.00%-129.97K-80.49%10.72K116.84%12.49K-146.17%-229.27K-291.95%-118.55K-145.97%-91.53K577.77%54.96K-132.58%-74.16K197.81%496.6K108.79%61.76K
-Change in receivables --------132.00%54.53K-176.29%-118.3K-59.77%23.85K---------248.89%-170.39K5,961.69%155.06K--59.27K
-Change in prepaid assets ---------48.40%12.26K-220.61%-6.39K-139.79%-20.91K--------17.88%23.76K114.76%5.29K--52.56K
-Change in payables and accrued expense ---------47.91%49.03K-158.30%-134.23K-621.87%-123.92K--------1.20%94.13K148.53%230.25K---17.17K
-Change in other working capital ---------376.88%-103.34K-72.04%29.64K107.40%2.44K-----------21.67K--106K---32.9K
Cash from discontinued investing activities
Operating cash flow 77.98%-110.37K-196.28%-201.57K-33.35%-245.94K23.58%-838.61K-1,563.75%-84.93K-191.16%-501.22K85.84%-68.03K59.05%-184.43K74.67%-1.1M100.34%5.8K
Investing cash flow
Cash flow from continuing investing activities 0096.55%-1.05K78.18%-78.56K-15.61%-19.64K54.82%-19.31K95.65%-9.17K66.00%-30.44K82.77%-360.04K-102.80%-16.99K
Net PPE purchase and sale --0--096.55%-1.05K78.18%-78.56K-15.61%-19.64K54.82%-19.31K95.65%-9.17K66.00%-30.44K-329.51%-360.04K-44.39%-16.99K
Cash from discontinued investing activities
Investing cash flow --0--096.55%-1.05K78.18%-78.56K-15.61%-19.64K54.82%-19.31K95.65%-9.17K66.00%-30.44K82.77%-360.04K-102.80%-16.99K
Financing cash flow
Cash flow from continuing financing activities -105.74%-35.95K36.24%383.8K-151.82%-31.97K-6.69%974.7K118.37%5.25K66.53%626.05K56.75%281.7K-88.08%61.7K-85.09%1.04M76.54%-28.6K
Net issuance payments of debt 0.85%-32.45K0.89%-32.01K16.53%-31.97K-121.78%-225.37K-326.78%-122.04K-108.71%-32.73K-117.97%-32.3K-107.55%-38.3K-14.33%1.03M76.54%-28.6K
Net common stock issuance --0--0--012,027.69%1.21M--130K--665.58K--317.19K900.00%100K-99.84%10K--0
Net other financing activities 48.50%-3.5K13,130.65%415.81K-------12.69K---2.71K---6.8K---3.19K------------
Cash from discontinued financing activities
Financing cash flow -105.74%-35.95K36.24%383.8K-151.82%-31.97K-6.69%974.7K118.37%5.25K66.53%626.05K56.75%281.7K-88.08%61.7K-85.09%1.04M76.54%-28.6K
Net cash flow
Beginning cash position -24.83%274.06K-42.64%91.83K18.37%370.8K-56.85%313.26K33.16%470.11K89.89%364.59K-77.25%160.09K-56.85%313.26K410.60%726.05K-81.93%353.05K
Current changes in cash -238.66%-146.32K-10.89%182.23K-82.13%-278.96K113.94%57.53K-149.63%-99.32K-34.48%105.52K139.97%204.5K-584.62%-153.17K-170.70%-412.78K96.76%-39.79K
End cash Position -72.83%127.75K-24.83%274.06K-42.64%91.83K18.37%370.8K18.37%370.8K33.16%470.11K89.89%364.59K-77.25%160.09K-56.85%313.26K-56.85%313.26K
Free cash from 78.80%-110.37K-161.08%-201.57K-14.95%-246.99K37.07%-917.17K-834.50%-104.57K-142.23%-520.53K88.83%-77.21K60.21%-214.87K67.09%-1.46M99.35%-11.19K
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +7.99%
Sample Name
Sample Code
 +4.00%
Sample Name
Sample Code
 +2.86%
4
SINOPEC CORP
00386
+2.22%
5
CNOOC
00883
+1.66%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +46.25%
Sample Name
Sample Code
 +33.47%
Sample Name
Sample Code
 +26.48%
4
Loongson Technology Corporation
688047
+24.63%
5
Rockchip Electronics
603893
+19.54%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On May 1, the more than two-month-long military conflict involving the US, Israel, and Iran will reach a legal milestone, potentially increa Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -